Norden Group LLC Lowers Stake in Haleon plc (NYSE:HLN)

Norden Group LLC reduced its position in shares of Haleon plc (NYSE:HLN) by 51.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 23,578 shares of the company’s stock after selling 25,226 shares during the quarter. Norden Group LLC’s holdings in Haleon were worth $225,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Addison Advisors LLC raised its holdings in Haleon by 28.7% in the fourth quarter. Addison Advisors LLC now owns 4,954 shares of the company’s stock worth $47,000 after purchasing an additional 1,106 shares in the last quarter. Synovus Financial Corp lifted its stake in shares of Haleon by 0.8% during the third quarter. Synovus Financial Corp now owns 148,834 shares of the company’s stock worth $1,575,000 after buying an additional 1,216 shares during the period. Greenleaf Trust grew its stake in Haleon by 8.4% during the 4th quarter. Greenleaf Trust now owns 17,225 shares of the company’s stock valued at $164,000 after purchasing an additional 1,333 shares during the last quarter. Baron Wealth Management LLC boosted its position in Haleon by 4.3% in the fourth quarter. Baron Wealth Management LLC now owns 33,632 shares of the company’s stock valued at $321,000 after buying an additional 1,381 shares during the last quarter. Finally, Peapack Gladstone Financial Corp boosted its holdings in shares of Haleon by 3.2% in the 3rd quarter. Peapack Gladstone Financial Corp now owns 44,844 shares of the company’s stock valued at $474,000 after acquiring an additional 1,390 shares during the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Analyst Ratings Changes

Several research firms recently commented on HLN. Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Sanford C. Bernstein downgraded shares of Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Three research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $10.95.

Haleon Stock Performance

NYSE HLN opened at $10.68 on Wednesday. The stock’s fifty day moving average is $9.61 and its two-hundred day moving average is $9.84. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The firm has a market capitalization of $48.33 billion, a P/E ratio of 31.40, a price-to-earnings-growth ratio of 2.82 and a beta of 0.28. Haleon plc has a fifty-two week low of $7.89 and a fifty-two week high of $10.80.

Haleon (NYSE:HLN) last issued its quarterly earnings data on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The company had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. On average, research analysts anticipate that Haleon plc will post 0.43 earnings per share for the current year.

Haleon Increases Dividend

The company also recently announced a — dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be given a $0.1166 dividend. This is a positive change from Haleon’s previous — dividend of $0.05. The ex-dividend date of this dividend is Friday, April 25th. This represents a yield of 1.6%. Haleon’s payout ratio is presently 58.97%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.